(Q37803410)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20979551%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

title

3,4-diaminopyridine for the treatment of Lambert-Eaton myasthenic syndrome (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20979551%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20979551%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Jan J Verschuuren

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20979551%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

author name string

Paul W Wirtz

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20979551%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

Joop Ma van Gerven

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20979551%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

publication date

1 November 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20979551%20AND%20SRC:MED&resulttype=core&format=json

Expert Review of Clinical Immunology

14 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20979551%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

volume

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20979551%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20979551%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

page(s)

867-874

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20979551%20AND%20SRC:MED&resulttype=core&format=json

The Lambert-Eaton myasthenic syndrome. A review of 50 cases

14 January 2020

cites work

1 reference

Lambert-Eaton myasthenic syndrome has a more progressive course in patients with lung cancer

21 January 2018

1 reference

The action of Lambert-Eaton myasthenic syndrome immunoglobulin G on cloned human voltage-gated calcium channels

21 January 2018

1 reference

Practice parameter for repetitive nerve stimulation and single fiber EMG evaluation of adults with suspected myasthenia gravis or Lambert-Eaton myasthenic syndrome: summary statement

21 January 2018

1 reference

Favourable prognosis in Lambert-Eaton myasthenic syndrome and small-cell lung carcinoma

21 January 2018

1 reference

Plasmapheresis and immunosuppressive drug therapy in the Eaton-Lambert syndrome

21 January 2018

1 reference

3,4-Diaminopyridine in the treatment of Lambert-Eaton myasthenic syndrome

21 January 2018

1 reference

A randomized trial of 3,4-diaminopyridine in Lambert-Eaton myasthenic syndrome

21 January 2018

1 reference

Efficacy of 3,4-diaminopyridine and pyridostigmine in the treatment of Lambert-Eaton myasthenic syndrome: a randomized, double-blind, placebo-controlled, crossover study.

21 January 2018

1 reference

3,4-Diaminopyridine is more effective than placebo in a randomized, double-blind, cross-over drug study in LEMS.

21 January 2018

1 reference

3,4-diaminopyridine. A potent new potassium channel blocker

21 January 2018

1 reference

Evaluation of 4-aminopyridine and 3,4-diaminopyridine penetrability into cerebrospinal fluid in anesthetized rats.

21 January 2018

1 reference

Novel drug of choice in Eaton-Lambert syndrome

21 January 2018

1 reference

Preliminary trial of 3,4-diaminopyridine in patients with multiple sclerosis

21 January 2018

1 reference

Reliability testing of the quantitative myasthenia gravis score

21 January 2018

1 reference

3,4-Diaminopyridine (DAP) in the treatment of Lambert-Eaton myasthenic syndrome (LEMS).

21 January 2018

1 reference

3,4-diaminopyridine safety in clinical practice: an observational, retrospective cohort study.

21 January 2018

1 reference

Guidelines for the treatment of autoimmune neuromuscular transmission disorders

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ECI.10.57

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20979551%20AND%20SRC:MED&resulttype=core&format=json

14 January 2020

1 reference